Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
UNKNOWNN/A

Neuropsychiatric Research Databases for People With Intellectual Disabilities and Epilepsy (REFINE)

Sponsor: University of Plymouth

NCT ID: NCT06780501

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 8 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
600
Started
2024-09-12
Last checked
2024-09

Plain English Summary

What is this study?

  • • Testing a new treatment for epilepsy
  • • Clinical study - 600 participants
  • • This study consists of two parts: Part One: De-identified Database The goal of this part is to establish a research database containing de-identified data about People with Intellectual Disabilities (PwID) and epilepsy, collected from three NHS sites across England and Wales

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with epilepsy

Where?

  • • Bodmin - Cornwall Partnership NHS Foundation Trust
  • • London - Royal Free London Hospitals NHS Trust
  • • Swansea - Swansea Bay University Health Board

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This study consists of two parts: Part One: De-identified Database The goal of this part is to establish a research database containing de-identified data about People with Intellectual Disabilities (PwID) and epilepsy, collected from three NHS sites across England and Wales. Researchers will gather information from participants' medical records, including clinical details, epilepsy history, and medications, and will enter this data into a secure database where all identifying details are removed. This part of the study aims to determine whether it's possible to identify eligible participants, collect complete datasets for each participant, and identify any issues that may affect the quantity and quality of data. These findings will help inform a potential future study that could involve 20 or more sites. Part Two: Research Register The goal of this part is to create a research register of individuals with PwID and epilepsy. Participants will be approached and asked for their consent to collect their personal and clinical data, which will help identify those willing to take part in future ethically approved research projects. As in Part One, researchers will collect data from medical records. Participants who consent to be included in the register may be contacted by external researchers for future studies. The aim is to facilitate national collaboration by enabling data sharing between research projects, thereby improving the ability to answer more questions and enhance patient care. This part of the study will test whether it's possible to determine screening and recruitment rates at each site, develop and evaluate recruitment processes, and assess how researchers leading other approved studies can obtain permission to use the register. Additionally, it will evaluate whether it's possible to collect a complete dataset for each participant.

EpilepsyIntellectual DisabilityLearning Disability

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Clinical diagnosis of ID in medical records.
  • ✓Clinical diagnosis of epilepsy in medical records.
  • ✓Patient is over the age of 18 years old.
  • ✓Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.

Who cannot take part

  • ✗Other neurodevelopmental disorders without ID.
  • ✗Patient is recorded on the National Data Opt-out as not wishing their data to be used for research/audit.
  • ✗The research register:
  • ✗Inclusion Criteria:
  • ✗Clinical diagnosis of ID in medical records.
See the full criteria
The de-identified database: Inclusion Criteria: * Clinical diagnosis of ID in medical records. * Clinical diagnosis of epilepsy in medical records. * Patient is over the age of 18 years old. * Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts. Exclusion Criteria: * Other neurodevelopmental disorders without ID. * Patient is recorded on the National Data Opt-out as not wishing their data to be used for research/audit. The research register: Inclusion Criteria: * Clinical diagnosis of ID in medical records. * Clinical diagnosis of epilepsy in medical records. * Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts. * Between the ages of 18 and 30 at the time of consent. * Participant has the capacity to be able to provide consent for themselves, or a personal consultee is able to provide an opinion on the views and feelings of the potential participant. * Patients (or personal consultee) must be able to communicate in English (or Welsh in Welsh site). Exclusion Criteria: \- Other neurodevelopmental disorders without ID.

Where Is This Study? (3 UK sites)

Cornwall Partnership NHS Foundation Trust

Bodmin, United Kingdom

Recruiting
Site contact (verified)
Sarah LennardPrincipal Investigator

Royal Free London Hospitals NHS Trust

London, United Kingdom

NOT_YET_RECRUITING
Site contact (verified)
Heather Angus-LeppanPrincipal Investigator

Swansea Bay University Health Board

Swansea, United Kingdom

Recruiting
Site contact (verified)
Lance WatkinsPrincipal Investigator

How to Get in Touch

Rohit Shankar

Sponsor contact

CONTACT

+44 (0) 1752 439831 rohit.shankar@plymouth.ac.uk

Emily Stanyard

Sponsor contact

CONTACT

+44 (0) 1752 439831 emily.stanyard@plymouth.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2024-09